2018 was a ground-breaking year for orphan disease with the FDA approving a record 34 new therapies for rare populations. Clearly, the steps laid out
The bad news is healthcare providers have never been more difficult for sales forces to reach. The good news is that HCPs are increasingly embracing
Bigger isn’t necessarily better when it comes to digital marketing.
Winning techniques for pharma marketers to find, grow and keep their disease community
Leverage a scorecard to evaluate media partners
Guide evolved pharma portfolio management and planning with these principles